HIRA to cut off drugs of high cost for the effect.

Published: 2005-06-16 06:57:00

Updated: 2005-06-16 06:57:00

In the conference to discuss "Introduction of drug economic evaluation system" jointly sponsored by the Health Insurance Review Agency (HIRA) and the Korea Society of health economy and policy on June 14, the HIRA may cut off too expensive drugs for its efficacy or at least reduce its price by ev...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK